Utilizing Index of Refraction Monitors in Biopharmaceutical Downstream Processing and Purification When the FDA published the 2003 document, “Pharmaceutical Current Good Manufacturing Practices (CGMPs ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback